HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

George D Dangas Selected Research

Ioxaglic Acid (Ioxaglate Meglumine)

3/2016One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
5/2009Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


George D Dangas Research Topics

Disease

73Myocardial Infarction
12/2022 - 08/2006
69Thrombosis (Thrombus)
12/2022 - 02/2005
60Hemorrhage
12/2022 - 02/2004
37ST Elevation Myocardial Infarction
01/2018 - 10/2009
24Coronary Artery Disease (Coronary Atherosclerosis)
12/2022 - 04/2004
23Cardiovascular Diseases (Cardiovascular Disease)
02/2022 - 09/2011
21Stroke (Strokes)
12/2021 - 02/2004
20Diabetes Mellitus
01/2021 - 04/2004
17Acute Coronary Syndrome
01/2021 - 02/2011
17Death (Near-Death Experience)
12/2020 - 02/2004
11Anemia
11/2021 - 03/2007
10Aortic Valve Stenosis (Aortic Stenosis)
11/2021 - 08/2011
10Ischemia
01/2020 - 02/2004
8Atrial Fibrillation
01/2022 - 07/2015
7Acute Kidney Injury (Acute Renal Failure)
10/2021 - 06/2014
7Coronary Disease (Coronary Heart Disease)
05/2021 - 03/2012
7Chronic Renal Insufficiency
12/2020 - 08/2004
6Pathologic Constriction (Stenosis)
10/2015 - 02/2005
5Infarction (Infarctions)
06/2014 - 03/2012
4Heart Failure
11/2022 - 06/2014
4Ischemic Stroke
07/2019 - 01/2018
4Thrombocytopenia (Thrombopenia)
01/2016 - 06/2004
3Hypertension (High Blood Pressure)
11/2022 - 12/2012
3Atherosclerosis
01/2022 - 08/2011
3Inflammation (Inflammations)
01/2022 - 02/2015
3Bundle-Branch Block (Fascicular Block)
11/2021 - 01/2020
3Peripheral Arterial Disease
08/2011 - 02/2004
3Aneurysm (Aneurysms)
08/2011 - 08/2006
3Hematoma
06/2010 - 02/2004
2Hypotension (Low Blood Pressure)
11/2022 - 08/2004
2Cardiogenic Shock
01/2022 - 08/2006
2Thromboembolism
01/2021 - 12/2016
2Chronic Kidney Failure (Chronic Renal Failure)
10/2018 - 05/2009
2Patent Foramen Ovale
10/2018 - 09/2018
2Non-ST Elevated Myocardial Infarction
01/2018 - 09/2015
2Atherosclerotic Plaque (Atheroma)
11/2016 - 04/2014
2Stable Angina
09/2015 - 06/2011
2Transient Ischemic Attack
04/2015 - 02/2004
2Neointima
12/2006 - 11/2004
2Hyperplasia
12/2006 - 11/2004
1Pericarditis
01/2022
1Postpericardiotomy Syndrome
01/2022
1Gout
01/2022
1Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve)
01/2022
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2022
1Familial Mediterranean Fever (Periodic Disease)
01/2022
1Heart Diseases (Heart Disease)
10/2021
1Left Ventricular Outflow Obstruction
07/2021
1Body Weight (Weight, Body)
05/2021
1Vascular Diseases (Vascular Disease)
05/2021

Drug/Important Bio-Agent (IBA)

25bivalirudin (Angiomax)FDA Link
11/2021 - 03/2007
25Heparin (Liquaemin)FDA LinkGeneric
11/2021 - 06/2004
23omega-Chloroacetophenone (Mace)IBA
02/2022 - 10/2009
13Glycoproteins (Glycoprotein)IBA
10/2016 - 08/2009
112'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2021 - 01/2013
9Hemoglobins (Hemoglobin)IBA
11/2021 - 12/2014
9Insulin (Novolin)FDA Link
01/2020 - 04/2004
8Biomarkers (Surrogate Marker)IBA
01/2020 - 03/2007
6Sirolimus (Rapamycin)FDA Link
01/2021 - 11/2004
6Clopidogrel (Plavix)FDA Link
01/2021 - 04/2011
6Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 03/2008
5Vitamin KFDA Link
01/2022 - 03/2012
5AnticoagulantsIBA
12/2021 - 11/2012
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2019 - 03/2012
5Pharmaceutical PreparationsIBA
01/2019 - 09/2009
5CreatinineIBA
08/2015 - 06/2010
4MetalsIBA
02/2015 - 03/2009
3edoxabanIBA
01/2022 - 11/2018
3C-Reactive ProteinIBA
01/2021 - 02/2011
3TicagrelorIBA
01/2021 - 12/2015
3RivaroxabanIBA
01/2020 - 02/2017
3Fibrinolytic Agents (Antithrombotic Agents)IBA
10/2018 - 06/2004
3fibrin fragment D (D-dimer)IBA
07/2016 - 02/2013
3EverolimusFDA Link
11/2014 - 10/2011
3AntithrombinsIBA
06/2011 - 02/2011
2Biological ProductsIBA
12/2022 - 02/2018
2MB Form Creatine KinaseIBA
01/2020 - 01/2014
2CholesterolIBA
01/2019 - 11/2016
2iodixanol (Visipaque)FDA Link
03/2016 - 05/2009
2Ioxaglic Acid (Ioxaglate Meglumine)FDA Link
03/2016 - 05/2009
2Protamines (Protamine Sulfate)FDA Link
01/2016 - 05/2013
2Contrast MediaIBA
08/2015 - 05/2009
2thienopyridineIBA
03/2012 - 08/2009
1Sodium-Glucose Transport ProteinsIBA
09/2022
1Sodium-Glucose Transporter 2 InhibitorsIBA
09/2022
1ColchicineFDA LinkGeneric
01/2022
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2022
1Sodium Bicarbonate (Baking Soda)FDA LinkGeneric
10/2021

Therapy/Procedure

85Stents
12/2022 - 11/2004
68Percutaneous Coronary Intervention
01/2022 - 02/2004
31Therapeutics
12/2022 - 02/2011
19Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2022 - 02/2004
19Drug-Eluting Stents
01/2019 - 03/2008
17Transcatheter Aortic Valve Replacement
12/2021 - 05/2013
5Blood Transfusion (Blood Transfusions)
02/2022 - 02/2004
3Prostheses and Implants (Prosthesis)
11/2021 - 12/2016
2Heart-Assist Devices
01/2022 - 01/2015
2Drug Therapy (Chemotherapy)
07/2016 - 12/2015
2Catheters
06/2014 - 04/2010
1Sutures (Suture)
07/2021